Patent 7619091 was granted and assigned to Prana Biotechnology Ltd on November, 2009 by the United States Patent and Trademark Office.
The present invention relates to a method for the treatment, amelioration and/or prophylaxis of a neurological condition, in particular neurodegenerative disorders which comprises the administration of an effective amount of a compound of formula (I): to a subject in need thereof. The present invention also relates to a compound of formula (II) and processes for its preparation.